Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Exercise and Cardiovascular Response

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

Exercise and Cardiac Output

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...

Heart Failure Drugs: β-Blockers

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Toward an integrated multi-gigahertz ionizing particle diagnostic.

The Review of scientific instruments·2024

Same author

Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL.

Journal of endocrinological investigation·2024

Same author

Author Correction: Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.

European review for medical and pharmacological sciences·2024

Same author

Reply letter to Adeli and Jazi - "Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion".

European review for medical and pharmacological sciences·2024

Same author

The Relationship between the Level of Coagulative Function Hypertensive Disorder Complicating Pregnancy.

Nigerian journal of clinical practice·2024

Same author

3D Printed Ion-Responsive Personalized Transdermal Patch.

ACS applied materials & interfaces·2024

Search research articles

Related Experiment Video

Updated: May 24, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

HBOC attenuates intense exercise-induced cardiac dysfunction.

T Li¹, D Zhu, R Zhou

¹West China Hospital, Sichuan University, Department of Anesthesiology, Chengdu, China. scutaoli1981@gmail.com

International Journal of Sports Medicine

|March 2, 2012

Summary

Hemoglobin-based oxygen carrier (HBOC) protects the heart from exercise-induced dysfunction by improving oxygen delivery and reducing oxidative stress. Pre-treatment with HBOC attenuated myocardial damage and improved cardiac function after prolonged intense exercise.

More Related Videos

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Related Experiment Videos

Last Updated: May 24, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Area of Science:

Cardiology
Exercise Physiology
Biochemistry

Background:

Intense, prolonged exercise can induce myocardial dysfunction and oxidative stress.
Hemoglobin-based oxygen carriers (HBOCs) are investigated for their potential therapeutic benefits.

Purpose of the Study:

To determine if HBOC pre-treatment can protect the heart against dysfunction caused by intense, prolonged exercise.
To investigate the mechanisms underlying HBOC's potential cardioprotective effects.

Main Methods:

Adult male rats underwent 5 hours of treadmill running with or without HBOC pre-treatment.
Cardiac function was assessed via heart rate, oxygen delivery, echocardiography, and Langendorff perfusion.
Biomarkers of myocardial injury (CK-MB, cTnI) and oxidative stress (SOD, H2O2) were measured.

Main Results:

HBOC pre-treatment attenuated exercise-induced left ventricular (LV) dysfunction.
Improved cardiac function markers (FS, RPP, ±dp/dt, CF) and reduced myocardial necrosis were observed with HBOC.
HBOC reduced cardiac enzyme release and inhibited exercise-induced oxidative damage by increasing SOD activity and decreasing H2O2.

Conclusions:

HBOC pre-treatment demonstrates a significant cardioprotective effect against prolonged exercise-induced cardiac dysfunction.
The cardioprotection is likely mediated by the reduction of myocardial oxidative stress.
HBOCs represent a promising therapeutic strategy for preventing exercise-related cardiac injury.